prostate cancer resource toolkit
Prostate Cancer Screening Guidelines Will Fail by 2026
In 2022, the United States spent about 17.8% of its GDP on healthcare, underscoring the urgency of efficient prostate cancer pathways. Prostate cancer resource toolkits are collections of evidence-based guides, referral charts, and patient-centered materials that help clinicians diagnose, refer, and support patients faster. By pulling together CDC screening